Analyst Consensus ?
ConsensusHold13 ratings
Bullish646.2%
Neutral753.8%
Bearish00.0%
Veralto Corporation · VLTO · FY2026 Q3 · Calendar Q4 2026
Veralto raises 2026 EPS outlook as water demand accelerates
Veralto's Q3 results support a constructive operating picture: growth remained broad, full-year adjusted EPS guidance increased, and management cited acquisition synergies, cost savings, and secular water-treatment demand. Execution and the durability of some benefits remain key tests.
Reported After market closeNYSEIndustrials
$25.34B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.18
Consensus $1.09
EPS surprise
+8.3%
Reported versus consensus
Reported revenue
$1.51B
Consensus $1.50B
Revenue surprise
+0.8%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+9.8%
Event window
SPY move
-1.9%
Same window
Abnormal move
+11.6%
Stock minus SPY
Volume
0.9×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
VLTOSPY benchmark
Ask FN2 about VLTO FY2026 Q3
Transcript, numbers and history already loaded
Why did VLTO rise 9.8% after beating EPS estimates in FY2026 Q3?What changed in VLTO's guidance and outlook in FY2026 Q3?Give me the bull and bear case for VLTO after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, Veralto's Q3 analysis shows a higher full-year adjusted EPS guidance range of $4.49-$4.52, up from $4.35-$4.43, alongside early 2026 cost savings of $10-$15 million. Cleanwater1, In-Siti, AQUAFIDES, and Alfaa UV were cited as contributing roughly 5% growth and expected synergies; Cleanwater1 is expected to dilute Q4 margins modestly before being EPS-neutral to slightly accretive.
Guidance delta
Raised: full-year adjusted EPS guidance increased to $4.49-$4.52 from the prior analysis's $4.35-$4.43 range. Management targets 5%-6% core sales growth and 10%-11% total growth in Q4.
Key takeaways
- Q3 sales increased 7.5% year over year, adjusted EPS rose 19.2%, and free cash flow was $304 million.
- Water Quality grew 6.4% organically and PQI grew 3.2% organically; management expects sequential acceleration in Q4.
- Recent acquisitions are expected to add roughly 5% sales growth and create revenue and cost synergies.
- Data-center chemical-treatment revenue doubled year over year from a small base, while digital workflow demand remained a growth driver.
Management priorities
- Integrate Cleanwater1, In-Siti, AQUAFIDES, and Alfaa UV.
- Deliver half of Cost Optimization savings by 2027 and the full run-rate by 2028.
- Expand data-center chemical treatment and direct-to-chip cooling offerings.
- Continue opportunistic share repurchases, with approximately $200 million remaining in the program.
Follow VLTO with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$113.07Current
$102Low
$108.81Average
$119High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Oct 5, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 30, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 30, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 30, 2026 |
| BNP Paribas | Outperform | Outperform | Maintain | Jul 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Jefferies | Hold | Buy | Downgrade | Dec 10, 2025 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 25, 2025 |
| Baird | Neutral | Neutral | Maintain | Jul 30, 2025 |
| TD Cowen | Hold | Hold | Maintain | Jul 30, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 29, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 29, 2024 |
| Vertical Research | Buy | Hold | Upgrade | Oct 16, 2023 |
Named analyst price targets
Upside is calculated against the persisted current price $113.07. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Stifel Nicolaus | Analyst unavailable | $113 | $101.04 | -0.1% | Oct 19, 2026 |
| UBS | Analyst unavailable | $106 | $94.68 | -6.3% | Oct 5, 2026 |
| UBS | Analyst unavailable | $104 | $94.18 | -8.0% | Jul 30, 2026 |
| Robert W. Baird | Analyst unavailable | $111 | $95.21 | -1.8% | Jul 30, 2026 |
| RBC Capital | Analyst unavailable | $109 | $94.8 | -3.6% | Jul 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $114 | $98.83 | +0.8% | Jul 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $111 | $93.81 | -1.8% | Jul 20, 2026 |
| Wolfe Research | Analyst unavailable | $109 | $92.12 | -3.6% | Jul 9, 2026 |
| Robert W. Baird | Michael Halloran | $103 | $89.47 | -8.9% | Apr 30, 2026 |
| Barclays | Analyst unavailable | $113 | $89.47 | -0.1% | Apr 30, 2026 |
| Stifel Nicolaus | Nathan Jones | $110 | $90.85 | -2.7% | Apr 14, 2026 |
| BMO Capital | Analyst unavailable | $108 | $92.81 | -4.5% | Feb 11, 2026 |
| UBS | Joshua Spector | $102 | $91.7 | -9.8% | Feb 6, 2026 |
| Stifel Nicolaus | Nathan Jones | $118 | $90.35 | +4.4% | Feb 5, 2026 |
| RBC Capital | Deane Dray | $102 | $89 | -9.8% | Feb 5, 2026 |
| Robert W. Baird | Michael Halloran | $108 | $91.41 | -4.5% | Feb 5, 2026 |
| Barclays | William Grippin | $117 | $91.41 | +3.5% | Feb 5, 2026 |
| Jefferies | Analyst unavailable | $105 | $98.34 | -7.1% | Dec 10, 2025 |
| BMO Capital | Analyst unavailable | $114 | $103.64 | +0.8% | Nov 25, 2025 |
| RBC Capital | Analyst unavailable | $111 | $100.26 | -1.8% | Oct 30, 2025 |
| Barclays | Analyst unavailable | $121 | $99.5 | +7.0% | Oct 30, 2025 |
| Barclays | William Grippin | $119 | $107.14 | +5.2% | Oct 6, 2025 |
| Barclays | Analyst unavailable | $120 | $107.06 | +6.1% | Sep 18, 2025 |
| Stifel Nicolaus | Analyst unavailable | $120 | $105.78 | +6.1% | Jul 30, 2025 |
| BMO Capital | John McNulty | $119 | $110.46 | +5.2% | Sep 30, 2024 |
| BMO Capital | John McNulty | $117 | $106.28 | +3.5% | Jul 29, 2024 |
| Stifel Nicolaus | Nathan Jones | $117 | $104.87 | +3.5% | Jul 29, 2024 |
| Robert W. Baird | Michael Halloran | $112 | $106.23 | -0.9% | Jul 29, 2024 |
| RBC Capital | Deane Dray | $108 | $106.25 | -4.5% | Jul 29, 2024 |
| Argus Research | John Eade | $110 | $97.27 | -2.7% | May 7, 2024 |
| BMO Capital | John McNulty | $101 | $92.4 | -10.7% | Apr 25, 2024 |
| RBC Capital | Deane Dray | $101 | $92.4 | -10.7% | Apr 25, 2024 |
| Goldman Sachs | Brian Lee | $104 | $89.46 | -8.0% | Mar 22, 2024 |
| RBC Capital | Deane Dray | $78 | $70.74 | -31.0% | Nov 3, 2023 |
Track every rating change on VLTO the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationVeralto Corporation is a global provider specializing in critical solutions across water quality management, brand protection, and packaging aesthetics. Its operations are structured into two primary divisions: Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment delivers advanced instrumentation and treatment technologies designed for the precise measurement, analysis, and purification of water. These solutions cater to a broad spectrum of applications, from residential and commercial settings to municipal systems, industrial processes, research facilities, and natural environments. Esteemed brands like Hach, Trojan Technologies, and ChemTreat fall under this segment, which also supplies essential chemical reagents, support services, and digital tools for comprehensive water management. The PQI segment focuses on enhancing product integrity and brand appeal.…
Historical context
All VLTO earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| GD General Dynamics Corporation | FY2026 Q3 · Calendar Q4 2026 | — | +0.8% | General Dynamics raises EPS outlook as backlog reaches $220 billion |
| MTZ MasTec, Inc. | FY2026 Q3 · Calendar Q4 2026 | +0.3% | +0.8% | MasTec posts record Q3 as power and data-center demand accelerates |
| RBC RBC Bearings Incorporated | FY2027 Q2 · Calendar Q4 2026 | — | -5.3% | RBC Bearings posts strong Q2 as capacity investments build |
| IR Ingersoll Rand Inc. | FY2026 Q3 · Calendar Q4 2026 | +18.5% | +0.2% | Ingersoll Rand raises FY2026 outlook as orders accelerate |
| CNI Canadian National Railway Company | FY2026 Q3 · Calendar Q4 2026 | — | +0.4% | CN pairs strong Q3 growth with productivity and network expansion |
| NVT nVent Electric plc | FY2026 Q3 · Calendar Q4 2026 | — | -7.5% | nVent raises 2026 outlook as data-center demand accelerates |
Latest beats and misses
Who reports nextBeat on EPS
- MTZFY2026 Q3 · October 29, 2026+0.3% EPS+0.8% move
- ERIEFY2026 Q3 · October 29, 2026+2.1% EPS+5.3% move
- IRFY2026 Q3 · October 29, 2026+18.5% EPS+0.2% move
- MSTRFY2026 Q3 · October 29, 2026+121.6% EPS-6.3% move
- EIXFY2026 Q3 · October 29, 2026+3.3% EPS-0.2% move
- STRKFY2026 Q3 · October 29, 2026+121.6% EPS-2.7% move
Missed on EPS
- AMZNFY2026 Q3 · October 29, 2026-4.1% EPS-1.6% move
- SYKFY2026 Q3 · October 29, 2026-0.8% EPS-5.0% move
- DLR-PJFY2026 Q3 · October 29, 2026-8.4% EPS— move
- DLRFY2026 Q3 · October 29, 2026-8.4% EPS-3.0% move
- EGFY2026 Q3 · October 28, 2026-18.8% EPS+3.5% move
- MKLFY2026 Q3 · October 28, 2026-2.3% EPS+1.2% move
Get the VLTO recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-30T17:05:39.131438+00:00
- FN2 earnings calendar · 2026-10-30T01:23:13.979536+00:00
- Polygon adjusted daily market bars · 2026-10-30T17:50:48.545457+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-30T17:50:48.542748+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-30. For educational purposes only; not investment advice.